Full name
ZESPÓŁ PRZYCHODNI SPECJALISTYCZNYCH DIAB-END-COR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
ZESPÓŁ PRZYCHODNI SPECJALISTYCZNYCH DIAB-END-COR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. BATOREGO 3, 31-135 KRAKÓW
TAX ID6762119168
Rate company:
ZESPÓŁ PRZYCHODNI SPECJALISTYCZNYCH DIAB-END-COR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6762119168
KRS0000123276
Share capital50,000.00 zł
address
UL. BATOREGO 3, 31-135 KRAKÓW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6762119168
REGON
357059146
KRS
0000123276
Legal form
limited liability company
Register Address
UL. BATOREGO 3, 31-135 KRAKÓW
Date of registration in KRS
2002-07-17
Date of commencement of economic activity
2002-07-17
Act signature
KR.XI NS-REJ.KRS/26047/23/542/ADE
Pkd codes
86.22.Z - Specialist medical practice
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
58.19.Z - Other publishing activities, excluding software publishing
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.90.A - Healthcare
86.90.C - Healthcare
86.90.E - Healthcare
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,4 | -0,8 | 2,1 | 370,9 |
EBITDA | 0,4 | -0,8 | 2,1 | 378,8 |
Short time liabilities | 0,3 | 0,4 | 0,1 | -57,8 |
Equity capital | 0,9 | -0,1 | 2 | 1861,8 |
Operating profit (EBIT) | 0,4 | -0,8 | 2,1 | 376,1 |
Assets | 1,3 | 0,3 | 2,1 | 520,7 |
Net profit (loss) | 0,4 | -0,8 | 2,1 | 346,6 |
Cash | 1,1 | 0,1 | 0,4 | 154,4 |
Net income from sale | 2 | 2,5 | 3,1 | 26,6 |
Liabilities and provisions for liabilities | 0,4 | 0,5 | 0,1 | -67,2 |
Working assets | 1,3 | 0,3 | 2,1 | 510,6 |
Depreciation | 0 | 0 | 0 | -51,2 |
% | % | % | p.p. | |
Profitability of capital | 41,5 | 753,9 | 105,5 | -648,4 |
Equity capital to total assets | 72,5 | -32,8 | 93 | 125,8 |
Gross profit margin | 21,2 | -31,9 | 68,3 | 100,2 |
EBITDA Margin | 22 | -31,1 | 68,5 | 99,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 46 | 52 | 17 | -35 |
Current financial liquidity indicator | 3.6382622718811035 | 0.7532681226730347 | 14.001028060913086 | 13,2 |
Net dept to EBITDA | -2.189302682876587 | 0.10166855901479721 | -0.16432026028633118 | -0,3 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Medicare Łukasz Waliczek
Gliwice
Telemedycyna Polska S.A.
Katowice
GABINET LEKARSKI JACEK SKÓRCZEWSKI
Bydgoszcz
Dermatolog Kraków
KRAKÓW
Med+reh Filip Pałczyński
Września
Klinika Dla Kobiet - Antykoncepcja Online
Spennymoor